[Embryopathies and fetal diseases of therapeutic origin].
D000014:Abnormalities, Drug-Induced; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D005260:Female; D005315:Fetal Diseases / Q000209:etiology*; D006728:Hormones / Q000009:adverse effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007231:Infant, Newborn; D011247:Pregnancy; D011832:Radiation Injuries; D011833:Radiation Injuries, Experimental; D013792:Thalidomide / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D000962:Antimalarials; D000970:Antineoplastic Agents; D006728:Hormones; D007004:Hypoglycemic Agents; D013792:Thalidomide
Les embryopathies et les foetopathies d'origine thérapeutique.